This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.
RSA 329:9-g · Annual Education Program
329:9-g Annual Education Program. – The board, in conjunction with the New Hampshire Medical Society and other prescribing and dispensing stakeholders, shall establish an annual education program that covers the prescribing of biosimilar and interchangeable biological products. Such program shall include a review of interchangeable biological products approved by the federal Food and Drug Administration (FDA) including any evaluation information in determining interchangeability. The annual education program shall be implemented by December 31, 2018 or prior to the first interchangeable biological product being approved by the FDA. Source. 2018, 164:5, eff. June 7, 2018. Examinations and Licenses
Source note
Source. 2018, 164:5, eff. June 7, 2018. Examinations and Licenses
Source history
- 2018, 164:5, eff. June 7, 2018. Examinations and Licenses
Related materials
Bills affecting or mentioning this RSA
- 2026 HB1292-FN reference · 2027-01-01
- 2026 HB1321 amend
- 2026 HB1335 amend · 2027-01-01
- 2026 HB1702-FN amend
- 2026 HB1735-FN reference
- 2026 HB1769-FN amend · 2027-01-01
- 2026 HB1772-FN-A amend
- 2026 HB1796-FN reference · 2027-01-01
- 2026 HB470 reference
- 2026 SB453 amend
- 2026 SB457-FN amend · 2027-01-01
- 2026 SB504-FN reference · 2027-01-01